BHV-7000

DB22041InvestigationalSmall molecule

BHV-7000 is under investigation in clinical trial NCT06419608 (Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression).

Mechanism: Pharmacologically active on Voltage-gated Potassium Channels
Curator reviewed
Code names: BHV-700 · BHV-7000

Resolves to

Compound

What you can answer from here — as of June 26, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of BHV-7000, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.